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Abstract 
When designing devices for biomedical diagnostics, increasing the signal to noise ratio is often 
critical for achieving clinically relevant sensitivity and limits of detection (LOD). In antibody-
based assays, the measured signal can be amplified through the replacement of molecular 
fluorophores with doped nanoparticles (NP). However, the benefits of using NPs can only be 
realized if the NPs are coated efficiently with detection antibody, have good colloidal stability 
and the ratio of specific to non-specific binding (NSB) is high enough. The main focus of this 
paper is on the optimization of the bioconjugation protocol for antibody labeling of NPs leading 
to improved assay performance. Two types of linkers were used: monovalent linkers 
(glutaraldehyde; sulfo-SMCC; and sulfo-SIAB), and three generations of dendrimers endowed 
with multivalent carboxylic functionality. Overall, the NP-IgG conjugates prepared using 
multivalent linkers showed a significantly lower LOD and higher sensitivity than their homo- or 
hetero-functional counterparts. The multivalent dendrimers also improved NP stability and 
reduced aggregation. Moreover, the dendrimers showed a higher reactivity with biological 




Fluorescent labels are used for a range of applications including immunosorbent assays[1, 
2], immunocytochemistry[3-5], flow cytometry[6, 7] and DNA/protein microarray analysis[8, 9]. 
Fluorescence is preferred because it combines high sensitivity with a low limit of detection 
(LOD)[10-12]. Current research in biomedical diagnostics is moving to inexpensive devices, 
using biochips that require small samples volumes with minimum sample manipulation and high 
reliability under various experimental conditions. To meet this new demand, fluorescent labels 
with improved physical and chemical properties are required: for example, high photostability 
and fluorescence intensity, with a reproducible signal under a variety of chemical and biological 
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conditions. Dye-doped silica nanoparticles[13-15] (NP) stand out as excellent candidates as it is 
possible to dope silica NPs with a large number of fluorophores, increasing the total fluorescence 
of the label significantly[16, 17]. Moreover, the fluorophore is protected inside a silica matrix, 
thereby increasing photostability[18, 19] and quantum efficiency[20, 21]. Silica NPs are also 
relatively non-toxic, chemically inert, and can be prepared in a range of sizes[22]. It also 
relatively easy to functionalize silica NP with bioreactive groups that enable facile 
bioconjugation[16, 22, 23].  
We have found inconsistencies amongst bioassay data obtained using the same silica NP 
label with the same capture antibody but prepared using different bioconjugation protocols. 
Moreover, each step in the conjugation process modifies the zeta potential of the NP, thus 
affecting colloidal stability. We believe this is a significant stumbling block in the development 
of silica NP labels. In 2006, Tan and colleagues[16] proposed a way of improving colloidal 
stability of silica NPs through the addition of a negatively charged non-reactive organosilane 
alongside the bioreactive organosilane. In this paper we extend this work and show the 
significance, both for colloid stability and for assay performance, of the choice of the bi-linker, 
used to conjugate the detection antibody to the functionalised NP. There are many commercially 
available bi-linkers, for example glutaraldehyde[7], adipic acid[24], and succinic anhydride[22, 
25]. Using glutaraldehyde, the biomolecule of interest is immobilized directly, via Schiff base 
formation. In many other cases additional chemicals are required for activation. 
While a lot of work has been published on the functionalization of silica NP with a 
reactive organosilane[16, 26], to our best knowledge, no systematic studies have been reported 
for the optimization of the linker chemistry. There is a great choice of commercial hetero- or 
homo-functional linkers available; however, their effect on NP stability, aggregation, solubility 
and efficiency of bioconjugation is poorly documented. This is striking, particularly when 
FRQVLGHULQJWKDWWKLVLVWKHDFWXDOOD\HU³VHQVHG´E\WKHPROHFXOHWREHODEHOHG)XUWKHUPRUHLQD
sensitive and functional bioassay, a NP labeled biomolecule must retain its specific binding to 
analyte, while keeping the non-specific adsorption (NSA) on the substrate to a minimum. 
Therefore, the focus of this work is to investigate the effect of the linker on NP stability and the 
performance of NP labeled molecules in a sandwich immunoassay. In particular, the LOD and 
sensitivity was determined for the detection of human IgG.  
For this study, three monovalent bilinkers (Glutaraldehyde, Sulfosuccinimidyl 4-[N-
maleimidomethyl]cyclohexane-1-carboxylate (sulfo-SMCC) and N-Sulfosuccinimidyl[4-
iodoacetyl]aminobenzoate (sulfo-SIAB)), and three multivalent linker molecules (dendrimers, 
generations 0, 1 and 2) were selected for the bioconjugation of NPs with antibodies. Multivalent 
dendrimers are attracting a great deal of interest for applications in biomedical diagnostics[27-
30], pharmacology / drug delivery[31, 32] [33], cancer research[34], and nanomedicine[35]. Their 
use in research is still unabated now, 30 years after their first reported synthesis by Vogtle[36]. 
Dendrimers are branched, structurally appealing, monodispersed compounds with a well-defined 
structure, in which the number and functionality of the functional groups can be tailored for the 
specific bioconjugation required. In this work we show that the multivalency of dendrimers leads 
to a higher efficiency in bioconjugation of detection antibodies and an improved assay 
performance. Such improvements are necessary for reducing costs in medical diagnostics, 
particularly where large numbers of samples are tested.  
 In this work we use near-infrared dye-doped silica NPs. At near infrared wavelengths 
there is low background interference from the fluorescence of biological molecules, solvent, and 
substrates. Furthermore, whole blood has a weak absorption in the NIR region, thus reducing the 
need for whole-blood filtering for assays using whole blood. NIR light can also penetrate skin and 
tissue to several millimeters and this can enable fluorescence detection in dermatological or in-
vivo diagnostic devices.  
The three bivalent linkers used in this study are shown in the top half of figure 1. The 
structure and mechanism for attachment of the carboxylic acid terminated dendrimers is shown in 
the bottom half of figure 1. Nanoparticles were characterized using transmission electron 





Triton ® X-100 (trademark Union Carbide), n-hexanol (anhydrous, >99%), cyclohexane 
(anhydrous 99.5 %), ammonium hydroxide (28 % in H2O > 99.99 %), tetraethylorthosilica 
(TEOS, 99.99 %), aminopropyltrimethoxysilane (APTMS, 97 %), aminopropyltriethoxysilane 
(APTES, 99 %), 3-(trihydroxysilyl)propyl methyl phosphonate, monosodium salt solution 
(THPMP, 42 wt % in water), absolute ethanol, monobasic sodium phosphate, dibasic sodium 
phosphate. phosphate buffered saline (PBS, pH 7.4, 0.01 M), Tween ® 20 (trademark Uniqema), 
glutaraldehyde (25 wt % in water), sodium azide (99.99 %) and albumin from bovine serum 
(BSA, 98 %) were all purchased from Sigma Aldrich Ireland, sulfo-SMCC and sulfo-SIAB were 
purchased from Pierce Chemical Company, dendrimers generations 1 and 2 were purchased from 
Frontier Scientific UK and used without further purification. Dendrimer generation 0 was 
synthesized in two simple steps starting from cyanuric chloride as starting material and purified 
on silica gel chromatography column prior to use[37]. Black 96 well plates used in the 
immunoassay were purchased from AGB Scientific Ireland. Deionised water (< 18 Mȍ was 
obtained from a Milli-Q system from Millipore Ireland. 
The dye used in this work is 4,5-Benzo-1'-ethyl-3,3,3',3'-tetramethyl-1-(4-
sulfobutyl)indodicarbocyanin-5'-acetic acid N-succinimidyl ester, or more commonly referred to 
as NIR-664-N-succinimidyl ester (purchased from Sigma Aldrich). This dye has a quantum 
efficiency of 23 %, a molar absorptivity of 187,000 L mol-1 cm-1 and fluorescence excitation and 




TEM micrographs were obtained using a Hitachi 7000 Transmission Electron Microscope 
operated at 100 kV. Images were captured digitally using a Megaview 2 CCD camera. Specimens 
were prepared by dropping aqueous solutions of the NPs onto a formvar carbon coated copper 
grid. Fluorescence measurements were performed on a Safire (Tecan) microplate reader. For 
NIR-664-N-succinimidyl ester-doped NPs, the excitation and emission wavelengths were set at 
672 nm and 700 nm, respectively. Dynamic light scattering (DLS) measurements were performed 




Synthesis of silica NPs 
Firstly, 1.62 mg NIR-664-N-succinimidyl ester was dissolved in 2 mL anhydrous n-hexanol. To 
this solution, was added APTES in ten molar excess.  We prepared NPs containing 2 wt % NIR-
664-succinimidyl ester using the microemulsion method[34]. Briefly, the microemulsion was 
formed by mixing cyclohexane oil phase (15 mL), n-hexanol co-solvent (1.6 mL), Triton ® X-
100 surfactant (3.788 g) and 2 mL of the dye conjugate in 30 mL plastic bottles. Following this, 
0.2 mL of TEOS and 0.16mL of NH4OH were added to start the growth of the silica NPs. The 
reaction was stirred for 24 hrs, after which 0.1 ml TEOS was added with rapid stirring.After 30 
minutes, 0.08 mL of the organosilane, 3-(trihydroxysilyl)propyl methyl phosphonate, 
monosodium salt solution (THPMP), (42 wt % in water) was added with stirring to prevent 
aggregation of the nanoparticles[18]. After a further 5 minutes, 0.02 mL of bioreactive 
organosilane, aminopropyltrimethoxysilane, (APTMS) was added to and the solution stirred for a 
further 12 hours. The APTMS has a free primary amine group for crosslinking to biomolecules. 
The NPs were separated from the solution with the addition of excess absolute ethanol and 
centrifuged twice with ethanol and once with deionised water. Sonication was used between the 
washing steps to resuspend the NPs. The NPs were dispersed in deionised water, at 2.0 mg / mL 
and stored in the dark at 4oC. The NPs were characterized by Dynamic Light Scattering, 
Fluorescence Spectrophotometer and Transmission Electron Microscopy (Fig. 2). 
 
Synthesis of dendrimer G0. 
 
Intermediate 1: To a pressure vessel containing 100 mL of CH2Cl2:MeOH (1:1), 2-Amino-2-
(hydroxymethyl)-1,3-SURSDQHGLRO  J  PPRO DQG +XQLJ¶V EDVH  J  PPRO ZHUH
added. The mixture was cooled in an ice bath before addition of cyanuric chloride (3 g, 16 mmol). 
The reaction was then allowed to warm up to room temperature and stirred for 24 hours before 4-
piperidine carboxylic acid (8.4 g, 65.2 mmol) and NH4OH (5 mL) were added. The reaction 
mixture was then heated up to 60°C and stirred overnight.  Upon cooling, the precipitates were 
filtered and the solvent was removed by evaporation. The residue was re-dissolved in water (20 
mL) and acidified to pH = 4-5. Precipitates were formed, filtered off and washed extensively with 
water to give off-white powder (3.44 g, 47 % yield). This intermediate was used in the second 
step without further purification.  
Dendrimer G0: Intermediate 1 (0.5 g, 1.1 mmol) and diglycolic anhydride (3g, 16 mmol) were 
placed in a sealed vessel and irradiated in a CEM microwave at 300 W, 120°C for 5 minutes. 
Upon cooling, precipitates were formed, the whole mixture was dissolved in water and the pH 
was adjusted to 4-5. The solution was concentrated and the residue was purified on silica gel 




All bioconjugation reactions were performed with the NIR-NP at the NP concentration of 
2mg/mL, cross-linker concentration of 4 mM and with 268 Pg of goat anti-human IgG.The 
conjugation protocols were optimized for each linker with respect to the nature of its reactive 
groups.  
Glutaraldehyde (4 Pmol) was added into a 1 mL solution of NIR-NP (2mg/mL) and gently shaken 
for 1 hour. The excess of unreacted linker was removed by means of centrifugation (3x) and the 
precipitates were dissolved in 946 PL of 0. 1 M PBS buffer, pH=7.4. To this solution, 54 PL (268 
Pg) of goat anti-human IgG was added and the mixture was allowed to shake for 4 hours. The 
excess of the unreacted protein was removed by repeated centrifugation (4x) and the final 
bioconjugation product was dissolved in 1 mL of 0.1 M PBS buffer, pH=7.4. Sodium azide 
(NaN3), as an anti-microbial agent was further added into the mixture so that its final 
concentration reached 0.01%. 
The bioconjugation reaction using the heterofunctional linkers comprised two steps. First, sulfo-
SIAB or sulfo-SMCC (4Pmol) were allowed to react with 1 mL of a solution of NIR-NP 
(2mg/mL) in 0.1 M PBS buffer, pH=7.2, containing 5 mM of EDTA for 30 minutes, after which 
the excess of the linker was removed by centrifugation. Second, 2-IminothiolaneHCl (16.8 nmol,  
7UDXW¶VUHDJHQWZDVUHDFWHGZLWKJRDWDQWL-human IgG (268 Pg, 1.68 nmol) in 250 PL of 0.1 M 
Phosphate Buffered Saline (PBS) buffer, pH=8.0, containing 5 mM of EDTA for 1 hour, after 
which the excess of the unreacted iminothiolane was removed using a Zeba desalting column 
(Pierce Chemical comp.). 
Both fractions were subsequently mixed together in a reaction vessel for 4 hours, while keeping 
the total volume of the solution to 1 mL. The reaction mixture was then purified by repeated 
centrifugation (4x) and re-dissolved in 0.1 M PBS buffer, pH=7.4, 0.01% NaN3. 
The ±COOH groups of all three generations of the dendrimers were first activated with 
EDC/NHS mixture in 0.1 M 2-(N-morpholino)ethanesulfonic acid (MES) buffer, pH=6.3 before 
reacting with the protein. For example, G0 (4Pmol, 7x -COOH) was dissolved in 0.5 mL of MES 
buffer. To this solution, NHS (42 Pmol, 1.5 equiv. per one -COOH group) and EDC (168 Pmol, 
6.0 equiv. per one ±COOH group) were added, the final volume was adjusted to 1 mL with MES 
buffer and the reaction was allowed to proceed for 30 minutes. The NHS activated dendrimer was 
then directly added into the NIR-NP (2mg/mL), while keeping the total volume to 1 mL. This 
mixture was allowed to react for 30 minutes; subsequently the excess of solution-free dendrimer 
was removed by centrifugation. The dendritic-modified NIR-NP were re-dissolved in 946 PL of 
MES buffer, pH=7.0 and goat anti-human IgG (135 Pg, 54 PL from stock) was added. The 
reaction was allowed to shake for 4 hours, then 100 PL of sodium bicarbonate buffer at pH=9.0 
was added to hydrolyze the remaining NHS esters into carboxyls and the mixture was purified by 
centrifugation (4x). The NIR-NP ± IgG bioconjugate was re-dissolved in 0.1 M PBS buffer, 
pH=7.4, with 0.01 w/v % NaN3 and 0.5 w/v % of BSA. 
All reactions in which NIR-NPs were used were performed under reduced light (reaction vessels 
wrapped up in aluminum foil) to prevent photo-bleaching and all final samples were stored in the 
dark at 4oC overnight before they were used in the immunoassay. 
 
Fluorescence linked immunosorbent assay (FLISA) 
   
A sandwich assay format was used to test the performance of the NPs conjugated to 
human IgG through the linkers shown in figure 1. In the first step 100 ȝL of polyclonal goat-anti 
human IgG, at 5 ȝg / mL was added to each well of a standard 96 well microplate. The plate was 
then incubated overnight at 4°C. To remove any non-adsorbed antibody the plate was rinsed three 
times with PBS and three times with PBS/0.05 % w/v Tween®. To prevent non-specific 
adsorption, 200 ȝL of 1 % w/v Bovine Serum Albumine (BSA) in PBS was added to each well 
and the plate incubated at 37 °C for 1 hour. The rinse cycle was then repeated. Following this, 
100 PL aliquots of human IgG in 0.1 % w/v BSA were added in a series of dilutions from 10,000 
ng / mL to 0.01 ng / mL to each well and the plate incubated at 37 °C for 1 hour. The rinse cycle 
was repeated to remove any non-specifically bound human IgG. Finally, 100 ȝL aliquots of 
polyclonal goat anti-human IgG conjugated NPs at optimized value of 0.2 mg / mL (determined 
by an assay performed at saturated levels of both the captured antibody (50 ȝg / mL) and the 
antigen (10,000 ng / mL) by varying the concentration of the detection antibody) were added to 
each well and the plate incubated for a further hour at 37 °C in the dark. Prior to analysis the plate 
was rinsed one more time.  
The fluorescence signal including standard deviation at each concentration of human IgG 
was determined from seven replicate experiments. The complete assay was fitted using a standard 
sigmoidal logistics fit (see below, left hand side) and the low concentrations of human IgG were 
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where, Where, Fc  is the fluorescence at antigen concentration C, Fo is the background 
fluorescence, Fmax is the maximum fluorescence at the highest loading of antigen, p is the power, 
and Co is the point of inflection. For the allometric function, k and m are the coefficient and 
power variables that define the gradient of the fit and l normalizes the fit with antigen 
concentration. 
The LOD of human IgG was defined as the concentration corresponding to a 
fluorescence signal 3 times the standard deviation of the background signal. The sensitivity of the 
assay (change in fluorescence signal with concentration of human IgG) was determined at a range 
of concentrations through differentiation of the allometric power function.  
 
Results and Discussion 
 
1. Effect of the crosslinkers on colloidal stability 
Maintaining a high degree of monodispersity of the dye-doped nanoparticles is 
fundamental to successful bioassays. Current approaches to prepare colloidal solutions with low 
polydispersity index are mostly based on electrostatic interactions. The post-synthetic 
modification of the particle surface with charged species (e.g. phosphates, carboxylic acids etc.) 
is not only aimed to provide some sort of reactive handles but primarily to reduce the particle 
aggregation[39]. While the biomolecules of interest that are to be linked with the nanoparticles 
are usually charged species (proteins, ssDNA etc.) and have stabilizing effect on the 
bioconjugates[40], little attention was paid to the effect of the crosslinker used in the step 
preceding the reaction with the antibody. As seen in figure 3, monovalent linkers, glutaraldehyde 
and sulfo-SMCC had actually a destabilizing effect on the NP with the tendency to form 
aggregates. Sulfo-SMCC showed two different populations, the first transition corresponding to 
the formation of trimers or tetramers, with an average diameter of 275 nm, and the second 
corresponding to larger aggregates with polydispersed characteristics. On the contrary, NPs 
modified with the multivalent dendrimers G1 and G2 showed only a small increase in particle 
diameter.  The zeta potential increased from -29.8mV to -47.9mV and -46.0mV for G1 and G2, 
respectively. The colloidal stability of dendrimer coated NPs is due to the significant increase in 
the ]potential on addition of the linker. This is because the NHS ester activated groups on the 
dendrimer are susceptible to hydrolysis, which leads to the formation of carboxylic groups that 
are negatively charged at physiological pH. Therefore, the electrostatic charge on the NP is 
increased and colloidal stability is maintained.  
Immobilization of a model protein, Green Fluorescent Protein (GFP), on the modified NP surface 
seemed to have little effect on the zeta potential of the NP modified with the charged G1 and G2, 
while the changes in case of neutral Glu and sulfo-SMCC were more dramatic (figure 3B).  
 
2. Optimisation of bioconjugation 
As noted in the Experimental section, the bioconjugation of the GFP on the dendrimer-modified 
surface was performed via a well-known technique for the conjugation of carboxyl to amine 
groups in peptides and proteins. The reaction between carboxylic acids and amines to form stable 
amides is commonly facilitated by an addition of a carbodiimide, such as 1-Ethyl-3-[3-
dimethylaminopropyl] carbodiimide hydrochloride (EDC). However, EDC itself is not 
particularly efficient in crosslinking because in the first step it forms an unstable O-acylisourea 
ester that is prone to fast hydrolysis and regeneration of the carboxyl.  The carboxylic acids of the 
dendrimers were therefore activated in the presence of a mixture of N-hydroxysuccinimide (NHS) 
and a dehydrating agent, EDC. NHS/EDC mixture is commonly used to convert ±COOH groups 
to semi-stable amine reactive NHS-esters.   We realized that the availability and the lifetime of 
the NHS esters on the dendritic linker would determine the reaction efficiency and yields in the 
conjugation with the biomolecule that needs to be labeled. The activation reaction with EDC and 
NHS is most efficient at slightly acidic pH and usually performed in MES buffer at pH 4.7-
6.0[41,42,27]. With that in mind, we decided to explore on the effect of some other variables 
present in the EDC/NHS activation step such as the molar excess of NHS per COOH group, the 
ratio of the EDC/NHS co-reactants and the reaction time needed for the COOH activation.  The 
optimum balance between the rate of aminolysis and the hydrolysis of the dendritic N-
succinimidyl esters was very important for maintaining high activity and specificity of the labeled 
antibody towards the antigen in the immunoassay. Green Fluorescence Protein (GFP) was used as 
a model protein in the conjugation to the dye-doped nanoparticles under various conditions. The 
coupling efficiency was then determined by means of fluorescence with the excitation maximum 
at 398 nm and emission maximum at 508 nm, far from the fluorescence maxima of the NIR-NPs. 
After much experimenting with various parameters, the optimal conditions were found and read 
as follows: reaction medium ± 0.1 M MES buffer, pH = 6.0; activation time ± 30 minutes; two 
fold molar excess of NHS reagent per COOH group and 4:1 ratio of EDC:NHS (Fig. 4).  
 
3. Concentration of the biomolecule 
Another very important parameter in the bioconjugation protocol is the concentration of 
the biomolecule that will comprise a monolayer on the NP surface. This amount is usually 
estimated and depends upon factors such as the molecular weight of the protein, its relative 
affinity for the particle and the particle size[43]. While the amount of protein required to achieve 
surface saturation can be calculated, the actual protein concentration in the reaction may be 
VXEVWDQWLDOO\KLJKHUWKDQWKH³PRQROD\HU HTXLYDOHQWRISURWHLQ´YDOXe. The optimal value is 
usually given by the coupling efficiency, concentration of the target molecules and the amount of 
the non-specific binding and is usually determined experimentally. Therefore, we decided to 
investigate the effect of the concentration of the protein on the reaction yield. We compared the 
coupling efficiency of two linkers, sulfo-SMCC and G2, in the bioconjugation reaction using a 
model protein, green fluorescence protein (GFP).  The reactions were carried out at two different 
concentrations of the GFP. First, the reaction was run with the amount of GFP representing 1.5 
equivalent of the theoretical value necessary for surface saturation, and then a second reaction 
was performed using 3.0 equivalents. Figure 5 shows the effect of the increased concentration of 
GFP from 1.5 to 3.0 equivalents on the conjugation efficiency. The normalized fluorescence 
signal for sulfo-SMCC nearly doubled at the higher GFP concentration (3.0) when compared to 
the lower GFP concentration (1.5). Nevertheless, it was still significantly lower than the signal 
observed for the multivalent G2 linker, and that applied even for the case when the G2 sample 
contained only 1.5 equivalents of GFP. It is also noteworthy that the differences between the 
conjugation efficiency of the two G2 samples were very small. It suggests that the multivalency 
of the dendrimer is a significant factor responsible for the improvement in the reaction yields 
even at lower protein concentration. This is very important, particularly when considering the 
cost of the bioorganic material that is used in bioconjugation reactions. 
 
4. Fluorescence-Linked Immunosorbent Assay 
 
In order to test the performance of the dye doped silica NPs, we carried out a standard 
fluorescence-linked immunosorbent assay for the detection of human IgG. We used a sandwich 
assay format, in which the capture and detection antibodies were polyclonal goat anti-human IgG. 
Seven different NP assays were performed using each of the mono- or multi- valent bilinkers. As 
seen in figure 6, all assays showed standard sigmoidal behavior, excluding NPs prepared using 
G2 dendrimer, where the signal did not saturate at high concentrations. This response is typical of 
multilayer adsorption and may be due to the poor solubility exhibited by larger dendrimeric 
structures. The normalized fluorescence ratio, at the highest concentration of human IgG, 
(Fmax/Fo) for multivalent NP labels was significantly greater than the fluorescence achieved from 
labels prepared using monovalent linkers (Figure 6 and table 1).  
 As seen in table 1, all the multivalent labels showed lower LOD than the monovalent 
linkers. Moreover, the LOD for G1 dendrimer was lower by two orders of magnitude than that for 
the popular and routinely used homofunctional linker glutaraldehyde. Therefore, NPs sensitized 
through the multivalent linkers are sensing lower concentrations of antigen and must be bound 
more efficiently to the antigen coated surface. From the work presented herein on the 
bioconjugation of GFP and other studies, it is likely the multivalent NPs are coated with several 
detection antibodies. This would increase the number of binding sites per label increasing the 
reactivity of the label. Furthermore, because the footprint of a single NP label is significantly 
larger than the diameter of antigen, it may be possible for two antigens to bind to a single NP at 
the same time. The LOD for the dendrimeric NPs compares favorably with published data on the 
detection of biotinylated hIgG using avidin labeled silica NPs, where an LOD of 1.9 ng / mL was 
observed[25].  
For all three labels prepared using dendrimeric cross-linkers the assay showed good 
sensitivity at low concentrations of human IgG, with G1 showing the best response. We presume 
that the main reason why G2 dendrimer was outperformed by its smaller multivalent counterparts 
is due to its increased capacity to capture the protein at multiple locations, which can then restrict 
the binding capability of the labeled-antibody. Nonetheless, for NP labels prepared using the 
monovalent bilinker no sensitivity was observed at concentrations of human IgG below 1 ng / 




Successful detection devices for biomedical diagnostics frequently require high sensitivity and 
low LOD. Moreover, a device for point-of-care diagnostics must be both inexpensive and reliable 
under a variety of experimental conditions. The data presented in this paper focused on fine-
tuning the bioconjugation protocol in the labeling of biologically relevant material with NPs. We 
employed two types of linkers: monovalent linkers (glutaraldehyde; sulfo-SMCC; and sulfo-
SIAB), and three generations of dendrimers with multivalent carboxylic functionality. The NPs 
prepared using dendrimer generation 1 showed a significantly lower LOD and higher sensitivity 
than the homo- and hetero-functional crosslinkers. The difference in performance is remarkable, 
particularly when compared with glutaraldehyde, one of the most common crosslinker still 
employed by many research laboratories. We believe the multivalency of the dendrimers is one of 
the most significant factors behind the increase in the detection sensitivity. As revealed in this 
work, dendrimers have a positive effect on NP stability and aggregation. Moreover, they are more 
reactive with biological materials, capable of immobilizing antibody at the appropriate surface 
density while maintaining its activity to the analyte of interest. These properties are required for 
managing cost, in the design and implementation of biomedical devices, where expensive 
biological materials are necessary. Dendrimers are structurally appealing molecules that have 
already shown their high potential in the surface science of bioassay devices and this study 
confirmed that they are emerging as a powerful tool for the labeling of biomolecules in 
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Figure 1 Monovalent and multivalent cross-linkers used in this work. Inset in the cartoon view of 
dendrimer depicting the activation of the carboxylic acids and the two competing reactions occurring on the 
carbonyl group. 
 
Figure 2 A TEM micrograph of dye doped silica NPs approximately 71 +/- 4 nm in total diameter. 
 
Figure 3 Dynamic Light Scattering data showing the rate of NP aggregation (A) as effect of the 
corresponding linker attached to its surface; and (B) change in zeta potential as a function of the change on 
the surface of the NPs 
Figure 4 Normalized fluorescence intensity measured after immobilization of Green Fluorescent Protein 
onto the NP surface. Optimal conditions were determined by (A) ± varying the stoichiometric ratio between 
EDC / NHS for the activation of G2 dendrimer for 30 minutes, followed by: (B) ± variations in the 
activation time of the G2 dendrimer at the optimum EDC/NHS ratio (4:1). 
Figure 5 Normalized fluorescence intensity measured after immobilization of Green Fluorescent Protein on 
the NP surface modified with sulfo-SMCC and the G2 dendrimer. In these reactions, both the amount of the 
NIR-NP and the cross linker were kept constant, and the concentration of the GFP was 1.5 or 3.0 
equivalents respectively. 1 equivalent represents an amount of protein (iQȝJWKDWLVQHFHVVDU\IRUDVXUIDFH
saturation of 1mg of the nanoparticles. This value was calculated according to the formula in ref. 36.  
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 Tables  
 
Homo-
0 1 2 Glut SMCC SIAB
Fmax/Fo 29.67 47.34 52.13 8.43 16.37 17.98
CV% (no analyte) 8.19 10.95 14.06 17.90 11.34 4.40
X(LOD (ng/mL) 1.66 0.31 2.67 41.96 7.55 7.09
Multi-valent linkers monovalent Linkers
Dendrimer generations Hetero-
 
Table 1 The total fluorescence signal over background fluorescence signal, F/Fo combined with coefficient 
of variance, and LOD results for each linker in the fluorescence linked immunosorbent assay for detection 
of human IgG 
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